Interferon Gamma (IFN γ)
Showing 1 - 25 of 3,283
MDS, Myeloid Leukemia, Allogeneic Stem Cell Transplantation Trial in Pittsburgh (IFN-? (interferon gamma-1b) injection)
Recruiting
- Myelodysplastic Syndromes
- +2 more
- IFN-γ (interferon gamma-1b) injection
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Jan 5, 2023
Interleukin 4 and Interferon Gamma Predictors of Human
Completed
- Warts Hand
- Wart, Genital
- IL-4 and IFN-γ measurements
-
Zagazig, Sharkia, EgyptZagazig University Faculty of Medicine
Oct 28, 2021
COVID-19 Respiratory Infection, Acute Respiratory Disease Trial in Moscow (Interferon gamma human recombinant (IFN-G))
Completed
- COVID-19 Respiratory Infection
- Acute Respiratory Disease
- Interferon gamma human recombinant (IFN-G)
-
Moscow, Russian FederationCity Clinical Hospital named after M.E. Zhadkevich Moscow City H
Sep 23, 2021
Interferon-gamma 1-b on Cells of Innate Immune System:
Completed
- Chronic Granulomatous Disease
- Interferon Gamma-1B
-
Aurora, ColoradoUniversity of Colorado Anschutz Medical Campus
Jan 20, 2021
Acute Leukemia, MDS Trial in Atlanta (Interferon gamma (IFN?)-primed human bone marrow-derived mesenchymal stromal cells)
Recruiting
- Acute Leukemia
- Myelodysplastic Syndromes
- Interferon gamma (IFNγ)-primed human bone marrow-derived mesenchymal stromal cells
-
Atlanta, Georgia
- +2 more
Jul 15, 2022
Anogenital Wart Trial in Makassar (Topical Ethanol Extract (Piper crocatum), Trichloroacetic Acid Topical)
Not yet recruiting
- Anogenital Wart
- Topical Ethanol Extract (Piper crocatum)
- Trichloroacetic Acid Topical
-
Makassar, South Sulawesi, IndonesiaWahidin Sudirohusodo General Hospital
Nov 14, 2022
Chronic Prostatitis Trial (Interferon gamma human recombinant (IFN-G))
Completed
- Chronic Prostatitis
- Interferon gamma human recombinant (IFN-G)
- (no location specified)
May 12, 2022
Metastatic Myxoid Liposarcoma, Metastatic Round Cell Liposarcoma, Metastatic Synovial Sarcoma Trial in United States (Interferon
Active, not recruiting
- Metastatic Myxoid Liposarcoma
- +15 more
- Interferon Gamma-1b
- +2 more
-
Palo Alto, California
- +6 more
Aug 2, 2022
Ingaron in Volunteers for the Prevention of COVID-19
Completed
- COVID-19 Respiratory Infection
- Interferon gamma human recombinant (IFN-G)
-
Moscow, Russian FederationCity Clinical Hospital named after M.E. Zhadkevich Moscow City H
May 20, 2022
CD4/CD8+ Interferon Gamma Release Assay for Monitoring
Active, not recruiting
- Tuberculosis
- Interferon gamma release assay (IGRA)
-
Milano, ItalyIRCCS San Raffaele Scientific Institute
Feb 13, 2023
Human Papillomavirus Infection, Anogenital Warts Trial in Moscow (Interferon gamma human recombinant (IFN-G))
Completed
- Human Papillomavirus Infection
- Anogenital Warts
- Interferon gamma human recombinant (IFN-G)
-
Moscow, Russian FederationState scientific center of a dermatovenereology and cosmetology
Nov 30, 2021
Macrophage Activation Syndrome, Lymphohistiocytosis, Hemophagocytic, Arthritis, Juvenile Trial in Worldwide (Emapalumab)
Completed
- Macrophage Activation Syndrome
- +3 more
-
Cincinnati, Ohio
- +4 more
May 16, 2022
Friedreich Ataxia Trial in Philadelphia (Interferon Gamma-1b)
Completed
- Friedreich Ataxia
- Interferon Gamma-1b
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Mar 23, 2021
Tuberculosis Trial in Shanghai (Placebo, Low dose adjuvant, High dose adjuvant)
Completed
- Tuberculosis
- Placebo
- +4 more
-
Shanghai, Shanghai, ChinaShanghai Public Health clinical Center
Mar 9, 2022
Pneumonia, Ventilator-Associated Trial in France (Interferon gamma, Placebo)
Not yet recruiting
- Pneumonia, Ventilator-Associated
- Interferon gamma
- Placebo
-
Lyon, France
- +6 more
May 2, 2023
Critically Ill Patients Trial in France, Greece, Spain (Recombinant Interferon gamma 1b (IMUKIN®), Recombinant Interferon gamma
Active, not recruiting
- Critically Ill Patients
- Recombinant Interferon gamma 1b (IMUKIN®)
- Recombinant Interferon gamma 1b placebo
-
Angers, France
- +17 more
Feb 1, 2022
Respiratory Syncytial Virus Infections Trial in Worldwide (RSVPreF3 OA investigational vaccine)
Active, not recruiting
- Respiratory Syncytial Virus Infections
- RSVPreF3 OA investigational vaccine
-
Mobile, Alabama
- +45 more
Jul 22, 2022
Performance Evaluation of the VIDAS TB-IGRA Assay.
Completed
- Active Tuberculosis
- +2 more
- Blood draw and IGRA test
-
Palo Alto, California
- +23 more
Jul 14, 2021
Dry Eye Disease Trial in Oslo (Thealoz Duo (combination of trehalose and hyaluronate) eye drop and Hyabak (hyaluronate) eye
Recruiting
- Dry Eye Disease
- Thealoz Duo (combination of trehalose and hyaluronate) eye drop and Hyabak (hyaluronate) eye drop
-
Oslo, NorwayThe Norwegian Dry Eye Clinic
Jun 27, 2022
Adenovirus Infection Trial in Columbus (Adenovirus Specific T lymphocytes)
Recruiting
- Adenovirus Infection
- Adenovirus Specific T lymphocytes
-
Columbus, OhioNationwide Children's Hospital
Sep 1, 2022
Autoimmune and Inflammatory Response Biomarkers in Fabry Disease
Recruiting
- Fabry Disease
-
Madrid, SpainHospital Universitario Ramón y Cajal
Aug 18, 2023
Obesity Trial in Kuala Lumpur (Tocotrienol-rich fraction vitamin E (TRF), Placebo)
Completed
- Obesity
- Tocotrienol-rich fraction vitamin E (TRF)
- Placebo
-
Kuala Lumpur, MalaysiaNational University Of Malaysia
Jun 7, 2023
Central Centrifugal Cicatricial Alopecia Trial in Winston-Salem (Calcipotriol, Subject's already prescribed drug)
Not yet recruiting
- Central Centrifugal Cicatricial Alopecia
- Calcipotriol
- Subject's already prescribed drug
-
Winston-Salem, North CarolinaWake Forest University Health Sciences
Jan 31, 2023
Hemophagocytic Lymphohistiocytoses, Cytokine Storm Trial in Hangzhou (Dexamethasone, Etoposide, Ruxolitinib)
Not yet recruiting
- Hemophagocytic Lymphohistiocytoses
- Cytokine Storm
- Dexamethasone
- +2 more
-
Hangzhou, Zhejiang, ChinaThe Children's Hospital of Zhejiang University School of Medicin
Aug 4, 2022